OMER vs ONC Stock Comparison

ONC currently leads OMER in this stock comparison, with AIQ scores of 80 vs 64. The clearest difference is risk resilience.

Market data as of Nov 15, 2026 market close· AIQ score gap 16 points
OMER
Healthcare
vs
ONC
Healthcare
OMER
Omeros Corporation
Price
$17.49
Day move
-2.78%
AIQ Score
64/100
Best edge
Balanced
Sector
Healthcare
ONC
BeOne Medicines AG
Leads
Price
$417
Day move
+0.14%
AIQ Score
80/100
Best edge
Risk Resilience
Sector
Healthcare

What is the main difference between OMER and ONC?

ONC leads the current stock comparison as BeOne Medicines AG, with the clearest separation coming from risk resilience and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Omeros Corporation vs BeOne Medicines AG

Data as of Nov 15, 2026· market close· Healthcare· Coverage 64/66 fields· High confidence
AIQ VerdictCompetitiveAIQ Comparison Conviction 7/10

ONC leads

ONC leads by 16 AIQ points, primarily on Risk Resilience and Quality, and the lead has widened from 10 points over 30 sessions. Wall Street currently favors OMER on target upside.

Competitive: 3 of 6 evidence groups support ONC, its lead is widening, and its current signal state is conflicted.

Evidence agreement: 3 of 6Comparison trend: Strengthening
OMER

Omeros Corporation

AIQ Score
64/100
AIQ Edge Score
7/10
ONC

BeOne Medicines AG

Leads
AIQ Score
80/100
AIQ Edge Score
10/10

The Algovestiq AIQ Score currently favors ONC over OMER, 80 versus 64 as of Nov 15, 2026. ONC's advantage is driven primarily by stronger risk resilience and quality. ONC also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors OMER. 3 of 6 covered evidence groups favor ONC today, and the comparison is rated Competitive on stability: only 3 of 6 covered evidence groups agree. ONC lead: Strengthening — the AIQ differential moved from 10 to 16 points over 30 sessions.

Compare Omeros Corporation and BeOne Medicines AG across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Price return from daily closes; distributions are not included.

OMER
+77.7%
ONC
+126.4%

Price return comparison

Growth of $10,000, price only

OMER $17,774 · ONC $22,638

Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.

Compare OMER and ONC against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

OMER advantage
0
ONC advantage
  • Risk Resilience33 vs 72
    ONC +39
  • Quality55 vs 78
    ONC +23
  • Momentum79 vs 91
    ONC +12
  • Value73 vs 71
    Even

3 of 6 evidence groups favor ONC. ONC’s edge is concentrated in risk resilience and quality.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

OMER0 AIQ

Largest factor move: Momentum -1, not enough on its own to move the overall score.

New signals

  • Low Volume Rally Warning — bearish, volume, short horizon (0.76x)
  • RSI Midline Rejection — bearish, momentum, short horizon
ONC0 AIQ

Largest factor move: Value +1, not enough on its own to move the overall score.

No signal started or stopped since the prior session; its 7 active signals are unchanged.

ONC's lead was unchanged in the latest session.

Deeper signal detail for each name lives on its own signals page — OMER and ONC both carry a full feed there.

The central trade-off

ONC (BeOne Medicines AG): the stronger current systematic profile, led by risk resilience and quality.

OMER (Omeros Corporation): the counter-case, on fundamentals, analyst expectations — but at materially higher volatility, 54.9% against 38.6%.

The AIQ Score and Wall Street therefore point in different directions on this pair.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

ONC

ONC on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

OMER

OMER on combined revenue and EPS growth.

Value

Even

The two are level on Value.

Momentum

ONC

ONC on the Momentum factor, by 12 points.

Lower downside

ONC

ONC on Risk Resilience, by 39 points.

Analyst upside

OMER

OMER on implied upside to the consensus price target.

AIQ vs Wall Street

The model and the Street disagree here: AIQ favors ONC, analyst targets favor OMER. That disagreement is the most useful thing on this page.

MeasureOMERONCNote
Implied upside to target+25.8%+5.1%OMER has more room
Target dispersion0%+12.6%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering327Higher coverage generally improves confidence

The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

3 of 6 covered evidence groups favor ONC. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreONC64 vs 80
FundamentalsOMERon balancerevenue growth 188.4% vs 10.8%; EPS growth -76.9% vs -87.5%; TTM ROE -25.8% vs 6.6%; gross margin 95.8% vs 88.4%; operating margin -189.5% vs 17.8% — OMER takes 3 of 5 decided legs, not all of them
ValuationEvenValue 73 vs 71
TechnicalsONCPrice vs 50-day -4.3% vs 12.8%; vs 200-day 27% vs 27.1%
Risk ResilienceONCRisk Resilience 33 vs 72
Analyst expectationsOMERTarget upside 25.8% vs 5.1%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of OMER and ONC and are excluded from the count.

AIQ Decision Stability

Competitive

The two are close enough that your objective, not the score, should decide.

  • The AIQ gap is wide at 16 points. (supports the conclusion holding)
  • Only 3 of 6 covered evidence groups agree. (argues the conclusion is provisional)
  • The leader's advantage has been widening. (supports the conclusion holding)
  • The lead has been steady session to session. (supports the conclusion holding)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on ONC.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

ONC lead: Strengthening — the AIQ differential moved from 10 to 16 points over 30 sessions.

May 27OMER leads above the line · ONC leads belowNov 13
Today
ONC +16
64 vs 80
7 sessions ago
ONC +13
65 vs 78
30 sessions ago
ONC +10
66 vs 76
90 sessions ago
ONC +11
58 vs 69

The lead has not changed hands in this window.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

OMERConflicted

1 bullish / 3 bearish / 2 neutral, conflicted

Only OMER

  • ADX Trend Weakening — neutral, trend, medium horizon
  • ATR Expansion - Breakout Mode — neutral, volatility, short horizon (5.14%)
  • Beta Spike Warning — bearish, risk_regime, long horizon
  • RSI Midline Rejection — bearish, momentum, short horizon
ONCConflicted

6 bullish / 1 bearish, conflicted

Only ONC

  • 52-Week High Proximity — bullish, risk_regime, long horizon (1.8%)
  • EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
  • Keltner Channel Breakout — bullish, volatility, short horizon
  • TRIX Bullish Signal — bullish, momentum, short horizon
  • Uptrend Structure Active — bullish, trend, long horizon

Both carry 2 more signals that do not separate them: Golden Cross Active, Low Volume Rally Warning.

ONC leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

OMERNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -2.78%, AIQ 0 points).

ONCNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +0.14%, AIQ 0 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1OMER closes the Risk Resilience gap — currently 39 points behind, the largest single contributor to ONC's edge.
  2. 2OMER's Beta Spike Warning resolves — a bearish risk_regime rule currently active against it.
  3. 3ONC's conflicting signal state resolves bearish — it currently carries 6 bullish and 1 bearish rules at once.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

OMER leads on balance
MetricOMERONC
Revenue growth (YoY)188.4%10.8%
EPS growth (YoY)-76.9%-87.5%
Gross margin95.8%88.4%
Operating margin-189.5%17.8%
Return on equity (TTM)-25.8%6.6%
Debt to equity-1.630.2

Performance

Split across windows
MetricOMERONC
1 week (5 sessions)3.4%2.4%
1 month (20 sessions)8%12.9%
3 months (63 sessions)0.7%14.9%
6 months (126 sessions)42.8%42%
Year to date1.8%37.1%
1 year (252 sessions)153.8%10.4%

Technicals

ONC has the stronger structure
MetricOMERONC
RSI (14)47.967.5
ADX (14)12.219.8
Price vs 50-day-4.3%12.8%
Price vs 200-day27%27.1%
Volatility (1M, annualized)54.9%38.6%

Risk

ONC is the more resilient
MetricOMERONC
Beta1.60.68
Sharpe ratio1.360.42
Sortino ratio3.040.62
Max drawdown-49.5%-30.9%
Current drawdown-16.9%-1.8%
Annualized volatility110.8%34.2%
Value at risk (95%)-6.7%-3%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, OMER or ONC?

On the Algovestiq AIQ Score, ONC is the stronger of the two as of Nov 15, 2026, scoring 80 against OMER's 64. The edge comes from risk resilience and quality. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is OMER or ONC the better buy right now?

ONC carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Competitive — 3 of 6 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.

Why does the AIQ Score favor ONC over OMER?

The composite weights Quality, Value, Momentum and Risk Resilience. ONC leads Risk Resilience by 39 points; ONC leads Quality by 23 points; ONC leads Momentum by 12 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, OMER or ONC?

Analyst price targets imply +25.8% upside for OMER and +5.1% for ONC, so the Street currently favors OMER. That points the opposite way to the AIQ Score, which favors ONC. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, OMER or ONC?

Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, OMER or ONC?

OMER on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, OMER or ONC?

ONC on the Momentum factor, by 12 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, OMER or ONC?

ONC is the more resilient of the two, so the other name carries the higher downside risk. ONC on Risk Resilience, by 39 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is OMER more profitable than ONC?

The profitability evidence is mixed: gross margin 95.8% vs 88.4%; operating margin -189.5% vs 17.8%; ttm roe -25.8% vs 6.6%. OMER leads on one measure and ONC on two measures, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.

Is ONC's lead over OMER getting stronger or weaker?

ONC lead: Strengthening — the AIQ differential moved from 10 to 16 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has not changed hands in that window.

What would change the OMER vs ONC verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: OMER closes the Risk Resilience gap — currently 39 points behind, the largest single contributor to ONC's edge; OMER's Beta Spike Warning resolves — a bearish risk_regime rule currently active against it; ONC's conflicting signal state resolves bearish — it currently carries 6 bullish and 1 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about OMER and ONC?

OMER: 1 bullish / 3 bearish / 2 neutral, conflicted. ONC: 6 bullish / 1 bearish, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on OMER is Golden Cross Active (bullish, long horizon). On ONC it is Golden Cross Active (bullish, long horizon).

Compare OMER and ONC with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.